Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)

HKG:3737 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	167.1	164.37	381.01	233.38	294.03
Short-Term Investments	32.59	25.66	23.66	15.67	16.43
Trading Asset Securities	-	2.28	14.69	8.8	0.58
Cash & Short-Term Investments	199.69	192.3	419.36	257.85	311.04
Cash Growth	3.84%	-54.14%	62.64%	-17.10%	-19.88%
Accounts Receivable	439.57	327.99	311.56	293.56	283.09
Other Receivables	8.53	8.47	6.71	13.88	2.17
Receivables	448.1	336.46	318.27	307.44	285.26
Inventory	345.35	330.02	322.9	268.06	247.12
Restricted Cash	2.11	-	-	-	-
Other Current Assets	18.87	15.34	30.39	24.1	40.47
Total Current Assets	1,014	874.12	1,091	857.44	883.88
Property, Plant & Equipment	730.44	664.12	573.6	547.31	432
Long-Term Investments	43.95	49.31	17.91	17	24.81
Goodwill	1.63	1.63	1.63	1.63	1.63
Other Intangible Assets	11.85	14.22	15.4	18.29	19.56
Long-Term Deferred Tax Assets	28.35	30.07	30.19	31.97	16.21
Other Long-Term Assets	156.78	159.17	145.61	50.47	42.44
Total Assets	1,987	1,793	1,875	1,524	1,421
Accounts Payable	295.96	190.97	189.78	120.83	110.44
Accrued Expenses	44.9	46.66	89.87	59.34	54.7
Short-Term Debt	-	-	36.03	57.24	78.92
Current Portion of Long-Term Debt	46.33	27.33	-	-	-
Current Portion of Leases	35.43	48.25	40.21	37.87	35.77
Current Income Taxes Payable	44.91	39.58	30.76	27.71	26.58
Current Unearned Revenue	13.79	33.13	134.97	29.81	35.53
Other Current Liabilities	250.26	222.68	209.64	168.02	143.53
Total Current Liabilities	731.56	608.61	731.25	500.83	485.47
Long-Term Debt	38.27	22.68	-	-	-
Long-Term Leases	68.57	76.59	94.62	80.62	73.22
Long-Term Unearned Revenue	7.91	11.87	15.84	15.43	14.22
Long-Term Deferred Tax Liabilities	19.26	19.55	27.59	26.06	25.86
Total Liabilities	865.58	739.3	869.31	622.94	598.76
Common Stock	6.85	6.85	6.85	6.85	6.65
Additional Paid-In Capital	63.59	86.73	202.87	202.87	173.03
Retained Earnings	1,022	927.28	764.51	658.12	605.99
Comprehensive Income & Other	23.59	27.66	28.75	30.9	34.51
Total Common Equity	1,117	1,049	1,003	898.74	820.18
Minority Interest	5.02	4.82	2.97	2.43	1.59
Shareholders' Equity	1,122	1,053	1,006	901.17	821.76
Total Liabilities & Equity	1,987	1,793	1,875	1,524	1,421
Total Debt	188.6	174.86	170.86	175.74	187.9
Net Cash (Debt)	11.09	17.45	248.5	82.1	123.14
Net Cash Growth	-36.45%	-92.98%	202.67%	-33.32%	-52.76%
Net Cash Per Share	0.01	0.02	0.29	0.10	0.15
Filing Date Shares Outstanding	863.6	863.6	863.6	863.6	840
Total Common Shares Outstanding	863.6	863.6	863.6	863.6	840
Working Capital	282.56	265.51	359.67	356.61	398.41
Book Value Per Share	1.29	1.21	1.16	1.04	0.98
Tangible Book Value	1,103	1,033	985.95	878.82	798.99
Tangible Book Value Per Share	1.28	1.20	1.14	1.02	0.95
Buildings	271.57	279.83	268.41	194.41	195.5
Machinery	268.92	250.64	221.23	181.43	141.66
Construction In Progress	221.69	110.59	29.86	116.37	35.45
Leasehold Improvements	192.2	184.08	187.73	164.24	143.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.